Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

We came across a bullish thesis on Viking Therapeutics, Inc. on r/wallstreetbets subreddit by Dritzz-9966. In this article, ...

Shares of companies will injectable GLP-1 drugs already on the market -- Eli Lilly and Novo Nordisk -- gained 2% and 2.7%, respectively, through 10:30 a.m. ET. Viking Therapeutics, which does not ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a ...

Within the pharmaceuticals industry in particular, shares of Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) are all looking to close out the week strong ...

Comparing Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of ...

Comparing Eli Lilly (LLY 1.79%) and Viking Therapeutics (VKTX 0.50%) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of ...

Comparing Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.